Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA-Reference-Cited by-同舟云学术

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA

Published:2015-03-03 Issue:11 Volume:60 Page:1715-1721
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Laanani Moussa,Ghosn Jade,Essat Asma,Melard Adeline,Seng Rémonie,Gousset Marine,Panjo Henri,Mortier Emmanuel,Girard Pierre-Marie,Goujard Cécile,Meyer Laurence,Rouzioux Christine

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/60/11/1715/16788696/civ171.pdf

Reference40 articles.

1. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents.;Panel on Antiretroviral Guidelines for Adults and Adolescents

2. Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort;Ghosn;J Antimicrob Chemother,2010

3. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy;Furtado;N Engl J Med,1999

4. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients;Goujard;Clin Infect Dis,2006

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating how HIV-1 antiretrovirals differentially behave as substrates and inhibitors of P-glycoprotein via molecular dynamics simulations;Computational and Structural Biotechnology Journal;2024-12

2. Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation;Journal of Clinical Investigation;2024-06-04

3. Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial;AIDS;2024-03-13

4. Factors associated with unquantifiable total HIV-1 DNA in peripheral blood in persons living with HIV: An observational study;Journal of Virus Eradication;2024-03

5. HIV-1 proviral DNA in purified peripheral blood CD34+ stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy;Heliyon;2024-02